Mesa Laboratories (MLAB)

Mesa Labs is a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, medical device, industrial safety, environmental, and food and beverage industries. Mesa offers products and services through four divisions (Sterilization and Disinfection Control, Biopharmaceutical Development, Instruments and Continuous Monitoring) to help its customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world.

Company profile

Ticker

MLAB

Exchange

NASDAQ

Website

www.mesalabs.com

CEO

Gary Owens

Incorporated

Colorado

Location

Colorado

Fiscal year end

Mar 31

Sector

Manufacturing > Instruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables

Industry (SIC)

Industrial Instruments For Measurement, Display, and Control

Danaher • Fortive • Roper • Ametek • Sensata Technologies Holding • Keysight • MKS Instruments • Cognex • Rudolph • Sypris Solutions ...

Former names

MESA LABORATORIES INC /CO

SEC CIK

0000724004

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

Agena Bioscience GmbH • Agena Bioscience, Inc. • Gyros DE GmbH • Gyros Finans AB • Gyros France Sarl • Gyros Patent AB • Gyros Protein Technology AB • Gyros Protein Technology Holding AB • Gyros U.K. Ltd. • Gyros U.S. Inc. ...

IRS number

840872291

MLAB stock data

1M 1Y 5Y

News

From Benzinga Pro

Mesa Laboratories: Q1 Earnings Insights

4 Aug 22

Mesa Laboratories (NASDAQ:MLAB) reported its Q1 earnings results on Thursday, August 4, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Mesa Laboratories Q1 EPS $1.17 Down From $1.72 YoY, Sales $50.45M Up From $34.92M YoY

4 Aug 22

Mesa Laboratories (NASDAQ:MLAB) reported quarterly earnings of $1.17 per share. This is a 31.98 percent decrease over earnings of $1.72 per share from the same period last year. The company reported $50.45 million in

Mesa Laboratories Q1 EPS $(0.27) Down From $1.72 YoY, Sales $50.45M Up From $34.92M YoY

4 Aug 22

Mesa Laboratories (NASDAQ:MLAB) reported quarterly losses of $(0.27) per share. This is a 115.7 percent decrease over earnings of $1.72 per share from the same period last year. The company reported $50.45 million in

Looking Into Mesa Laboratories's Return On Capital Employed

24 Jun 22

Stocks That Hit 52-Week Lows On Monday

13 Jun 22

Press releases

From Benzinga Pro

MESA LABS DECLARES QUARTERLY DIVIDEND

6 Jul 22

Lakewood, CO, July 06, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of

Mesa Laboratories Appoints Tony Tripeny to its Board of Directors

27 Jun 22

LAKEWOOD, Colo., June 27, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) announced the appointment of Tony Tripeny to its Board of Directors (the "Board"), effective June 23, 2022. Tony was previously

Mesa Labs Reports Fourth Quarter and Full Fiscal Year Results

31 May 22

LAKEWOOD, Colo., May 31, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the fourth quarter ("4Q22") and full year ended March 31, 2022 ("FY22"). Financial highlights for the

Calendar

4 Aug 22

12 Aug 22

31 Mar 23

Financial summary

Financial statements Chart MLAB financial data

Quarter (USD)	Jun 22	Mar 22	Dec 21	Sep 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Mar 22	Mar 21	Mar 20	Mar 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	43.75M	43.75M	43.75M	43.75M	43.75M	43.75M
Cash burn (monthly)	1.87M	19.33M	1.8M	290.92K	937K	(no burn)
Cash used (since last report)	2.68M	27.77M	2.59M	417.88K	1.35M	n/a
Cash remaining	41.07M	15.98M	41.16M	43.33M	42.4M	n/a
Runway (months of cash)	22.0	0.8	22.8	148.9	45.3	n/a

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Recent insider trades

MLAB insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
9 Aug 22	Tripeny R Tony	Common Stock	Buy	Acquire P	No	No	200	500	100K	500
5 Jul 22	Sullivan John James	Common Stock	Option exercise	Acquire M	No	No	122.66	15,000	1.84M	43,450
5 Jul 22	Sullivan John James	Common Stock	Option exercise	Acquire M	No	No	70.56	3,576	252.32K	28,450
5 Jul 22	Sullivan John James	Non Qualified Stock Option Common Stock		Dispose X	No	No	122.66	15,000	1.84M	450
5 Jul 22	Sullivan John James	Non Qualified Stock Options Common Stock		Dispose X	No	No	70.56	3,576	252.32K	15,450
21 Jun 22	Sakys John	Common Stock	Sell	Dispose S	No	No	188.224	722	135.9K	8,678
21 Jun 22	Sakys John	Common Stock	Grant	Acquire A	No	No	0	1,667	0	9,400
21 Jun 22	Dinoia Gregory	Common Stock	Sell	Dispose S	No	No	188.224	555	104.46K	3,634
21 Jun 22	Dinoia Gregory	Common Stock	Grant	Acquire A	No	No	0	1,278	0	4,189
17 Jun 22	Sakys John	Common Stock	Payment of exercise	Dispose F	No	No	185.57	173	32.1K	7,733

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

Institutional ownership, Q1 2022

MLAB institutional ownership history Ownership history

91.7% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	172	3	+5633.3%
Opened positions	169	0	NEW
Closed positions	0	166	EXIT
Increased positions	2	2	–
Reduced positions	1	1	–

13F shares	Current	Prev Q	Change
Total value	1.24B	268.13M	+361.6%
Total shares	4.86M	818.47K	+493.5%
Total puts	0	0
Total calls	0	0
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
BLK Blackrock	924.95K	$235.75M	NEW
Conestoga Capital Advisors	523.57K	$133.45M	-3.3%
Royce & Associates	356.64K	$90.9M	NEW
Vanguard	341.49K	$87.04M	NEW
IVZ Invesco	277.55K	$70.74M	+0.7%
STT State Street	197.33K	$50.29M	NEW
Ranger Investment Management	168.58K	$42.97M	NEW
Kayne Anderson Rudnick Investment Management	153.93K	$39.23M	NEW
Atlanta Capital Management Co L L C	135.31K	$34.49M	NEW
Schroder Investment Management	119.49K	$30.31M	NEW

Largest transactions	Shares	Bought/sold	Change
BLK Blackrock	924.95K	+924.95K	NEW
Royce & Associates	356.64K	+356.64K	NEW
Vanguard	341.49K	+341.49K	NEW
STT State Street	197.33K	+197.33K	NEW
Ranger Investment Management	168.58K	+168.58K	NEW
Kayne Anderson Rudnick Investment Management	153.93K	+153.93K	NEW
Atlanta Capital Management Co L L C	135.31K	+135.31K	NEW
Schroder Investment Management	119.49K	+119.49K	NEW
PFG Principal Financial Group Inc - Registered Shares	112.75K	+112.75K	NEW
Geode Capital Management	92.92K	+92.92K	NEW

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Financial report summary

Competition

Thermo Fisher Scientific • STERIS Plc (Ireland) • Amphenol • STERIS Plc (Ireland) • Fortive • Steris

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Avg

New words: abate, AgreementSM, anniversary, breadth, brought, carefully, China, composition, correlated, diversity, eased, easier, eventual, evolve, geographic, geography, hereditary, illustrative, inflationary, insurance, lessened, put, quarantine, removal, situation, smaller, speed, thereof, tradeshow, variation, website

Removed: accommodate, account, accounted, accruing, accurately, air, amortized, approval, approved, ASU, audit, behavior, bifurcate, billing, Butler, calculate, calendar, capacity, central, client, closure, collect, collecting, commencing, component, Consolidating, consolidation, consumable, contingency, contractor, convert, converting, customary, December, decrease, derecognized, determination, difficulty, distributing, eliminating, encourage, enhancing, Entity, established, event, examination, executed, exercise, exposed, FASB, feature, finalization, flow, fulfillment, full, gas, governing, GPT, Hedging, hired, identified, ii, iii, implemented, imposed, inception, indefinite, indenture, indirectly, initial, initially, instrument, invoiced, IRS, iv, Jersey, jurisdiction, knowledge, Lakewood, large, larger, law, lean, lingering, longer, marketing, measurement, modification, modified, notably, occurrence, positive, preacquisition, predict, preparing, prevent, program, projected, properly, realizable, received, recoverability, reduction, reinvestment, remit, remitted, remitting, rescinded, retrospective, reversal, sampling, secured, separation, slightly, standard, state, straight, streamline, subsidiary, substantially, support, supporting, technical, trading, transaction, transition, translated, transparency, unamortized, Unbilled, unconditional, undergoing, unrecognized, wholly

From filing 10-Q 2023 Q1

Financial reports

View all